BFOR vs. SBIO
Compare and contrast key facts about ALPS Barron's 400 ETF (BFOR) and ALPS Medical Breakthroughs ETF (SBIO).
BFOR and SBIO are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BFOR is a passively managed fund by SS&C that tracks the performance of the Barron's 400 Index. It was launched on Jun 4, 2013. SBIO is a passively managed fund by SS&C that tracks the performance of the S-Network Medical Breakthroughs Index. It was launched on Dec 31, 2014. Both BFOR and SBIO are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
BFOR vs. SBIO - Performance Comparison
Loading graphics...
BFOR vs. SBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BFOR ALPS Barron's 400 ETF | 0.80% | 13.85% | 17.81% | 18.19% | -15.92% | 30.71% | 17.60% | 21.30% | -13.86% | 19.37% |
SBIO ALPS Medical Breakthroughs ETF | 2.19% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
Returns By Period
In the year-to-date period, BFOR achieves a 0.80% return, which is significantly lower than SBIO's 2.19% return. Over the past 10 years, BFOR has outperformed SBIO with an annualized return of 11.62%, while SBIO has yielded a comparatively lower 9.65% annualized return.
BFOR
- 1D
- 2.41%
- 1M
- -5.32%
- YTD
- 0.80%
- 6M
- 2.85%
- 1Y
- 20.24%
- 3Y*
- 16.06%
- 5Y*
- 8.88%
- 10Y*
- 11.62%
SBIO
- 1D
- 8.92%
- 1M
- 1.52%
- YTD
- 2.19%
- 6M
- 34.69%
- 1Y
- 83.53%
- 3Y*
- 25.95%
- 5Y*
- 1.56%
- 10Y*
- 9.65%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BFOR vs. SBIO - Expense Ratio Comparison
BFOR has a 0.65% expense ratio, which is higher than SBIO's 0.50% expense ratio.
Return for Risk
BFOR vs. SBIO — Risk / Return Rank
BFOR
SBIO
BFOR vs. SBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Barron's 400 ETF (BFOR) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BFOR | SBIO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.02 | 2.51 | -1.49 |
Sortino ratioReturn per unit of downside risk | 1.55 | 3.16 | -1.60 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.40 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 1.63 | 4.44 | -2.81 |
Martin ratioReturn relative to average drawdown | 6.88 | 16.93 | -10.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BFOR | SBIO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.02 | 2.51 | -1.49 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | 0.05 | +0.41 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.29 | +0.28 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.56 | 0.22 | +0.33 |
Correlation
The correlation between BFOR and SBIO is 0.59, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BFOR vs. SBIO - Dividend Comparison
BFOR's dividend yield for the trailing twelve months is around 0.59%, while SBIO has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BFOR ALPS Barron's 400 ETF | 0.59% | 0.60% | 0.69% | 1.26% | 1.68% | 0.92% | 0.98% | 0.69% | 0.94% | 0.60% | 0.78% | 0.86% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% | 0.00% |
Drawdowns
BFOR vs. SBIO - Drawdown Comparison
The maximum BFOR drawdown since its inception was -41.27%, smaller than the maximum SBIO drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for BFOR and SBIO.
Loading graphics...
Drawdown Indicators
| BFOR | SBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.27% | -63.06% | +21.79% |
Max Drawdown (1Y)Largest decline over 1 year | -12.75% | -15.08% | +2.33% |
Max Drawdown (5Y)Largest decline over 5 years | -25.93% | -53.67% | +27.74% |
Max Drawdown (10Y)Largest decline over 10 years | -41.27% | -63.06% | +21.79% |
Current DrawdownCurrent decline from peak | -6.79% | -14.64% | +7.85% |
Average DrawdownAverage peak-to-trough decline | -6.49% | -28.71% | +22.22% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 4.53% | -1.51% |
Volatility
BFOR vs. SBIO - Volatility Comparison
The current volatility for ALPS Barron's 400 ETF (BFOR) is 5.74%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 12.96%. This indicates that BFOR experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BFOR | SBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.74% | 12.96% | -7.22% |
Volatility (6M)Calculated over the trailing 6-month period | 11.41% | 22.12% | -10.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.99% | 33.66% | -13.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.44% | 33.54% | -14.10% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.41% | 33.34% | -12.93% |